SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-004165
Filing Date
2024-03-28
Accepted
2024-03-28 07:55:58
Documents
18
Period of Report
2024-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20240327x8k.htm   iXBRL 8-K 89030
2 EX-4.1 xlo-20240327xex4d1.htm EX-4.1 104618
3 EX-10.1 xlo-20240327xex10d1.htm EX-10.1 246880
4 EX-10.2 xlo-20240327xex10d2.htm EX-10.2 229275
5 EX-99.1 xlo-20240327xex99d1.htm EX-99.1 30711
6 EX-99.2 xlo-20240327xex99d2.htm EX-99.2 42902
  Complete submission text file 0001558370-24-004165.txt   997408

Data Files

Seq Description Document Type Size
7 EX-101.SCH xlo-20240327.xsd EX-101.SCH 3116
8 EX-101.LAB xlo-20240327_lab.xml EX-101.LAB 16580
9 EX-101.PRE xlo-20240327_pre.xml EX-101.PRE 10710
21 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20240327x8k_htm.xml XML 5045
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 24793580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)